Physical Exam: VITALS:  T 98.2     HR 80     BP 133/64      RR 22   O2sat 99%RA  HEENT: Normocephalic, atraumatic.
RESP: Clear to auscultation bilaterally without adventitious sounds, minimally decreased breath sounds at bases bilaterally.
ABD: soft, non-tender, non-distended, with normoactive bowel sounds.
Pertinent Results: [**2116-5-10**] 06:00AM BLOOD WBC-9.2 RBC-3.58* Hgb-9.7* Hct-31.4* MCV-88 MCH-27.1 MCHC-30.8* RDW-18.4* Plt Ct-650*#  [**2116-5-9**] 07:55AM BLOOD PT-13.2 PTT-24.7 INR(PT)-1.1 [**2116-5-10**] 06:00AM BLOOD PT-14.6* PTT-25.2 INR(PT)-1.3* [**2116-5-11**] 03:50AM BLOOD PT-17.1* PTT-27.3 INR(PT)-1.5*  [**2116-5-10**] 06:00AM BLOOD Glucose-97 UreaN-21* Creat-1.2 Na-135 K-3.8 Cl-100 HCO3-27 AnGap-12  CXR ([**2116-5-5**]) - Stable postoperative findings indicative of CHF.
Fluid overload, as suggested in the requisition, may be a cause of these findings provided other cardiogenic factors are excluded.
Pathology ([**2116-4-29**]) - Rectum and sigmoid colon: Two synchronous colonic adenocarcinomas.
Serial EKGs were closely monitored without issue.
Vitals signs were closely monitored via telemetry.
Pulse oximetry was monitored closely and the patient maintained adequate oxygenations.
serial CXRs did reveal some evidence of atelectasis versus consolidation, along with pleural effusions (improved with diuresis) which was closely monitored.
A sputum sample revealed H. influenzae (non type-B) that was sensitive to Ampicillin.
GENITOURINARY: The patient's urine output was closely monitored in the immediate post-operative period.
The patient's creatinine was stable, his baseline being above normal.
Their white count was stable post-operatively and their incision was closely monitored for any evidence of infection or erythema.
Staples were removed from the superior aspect of the incision on POD#5 given some spreading peri-incisional erythema, and green-brown purulence was expressed and cultured.
Wound cultures demonstrated pan-sensitive pseudomonas and he has been on oral ciprofloxacin, which will continue until [**5-16**].
Blood glucose levels greater than 120 mg/dL were addressed with an insulin sliding scale.
Provider:  [**Name10 (NameIs) 676**] CLINIC Phone:[**Telephone/Fax (1) 62**] Date/Time:[**2116-12-2**] 3:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1008**], M.D.
Phone:[**Telephone/Fax (1) 62**] Date/Time:[**2116-12-2**] 4:00  Please make an appointment with your primary care provider to update them on your position.
